The Redox Podcast: Episode 36– Reproduction & Pediatrics pt 3: Dama Dipayana Co-founder & CEO of Manatee

Posted January 25, 2021
By Niko Skievaski

This was such a fun, multifaceted finale to our Reproduction & Pediatrics Podcast series. It’s always interesting to hear how people born outside the US stumble upon our healthcare system. Especially when they make it a point to explore business endeavors within it. Manatee made a splash on the health tech scene in 2019 by winning the HLTH pitch competition, TechStars, and Prime. Damayanti Dipayana, cofounder and CEO of Manatee, gives us a blunt and honest look into some of their decisions and how she manages her priorities while at the head of a fast-growing startup. She hints at an announcement so I’m definitely keeping my ears open for what’s brewing for their future.

Thanks for scheduling time with us Dama!

Now in a virtual setting, you really have to nail your onboarding process and think through how to get providers really excited about using and implementing your product.

Dama Dipayana

Key moments

  • 3:15 Difference healthcare in the US and healthcare in the Netherlands
  • 7:54 Why 2019 was such an explosive hear for Manatee 
  • 10:30 Dama’s vision for Manatee
  • 22:30  Manatee’s workflow and network effects
  • 29:55 Making sure to be clear around IP
  • 31:00 How Manatee has managed the COVID landscape
  • 37:55 3 Ps from the Cult of Dama
  • 42:00 Establishing constraints around productivity

You’ll want to listen to this podcast if you’re:

More on our Reproduction & Pediatrics Podcast series:

Niko’s Chat with Dr. Derick Elkin from the Center of Advancement for Youth

Our dive into Natural Cycles with Dr. Elina Berglund